In The News: Department of Brain Health
Neuroscientists show that chronic hyperglycemia affects fundamental aspects of memory.
In a new study from the University of Nevada, Las Vegas, researchers confirmed the link between type 2 diabetes and Alzheimer’s disease.
Eisai and Biogen announced that Eisai has initiated a rolling submission to the US Food and Drug Administration (FDA) of a Biologics License Application (BLA) for lecanemab (BAN2401), the company’s investigational anti-amyloid beta (Aß) protofibril antibody, for the treatment of early Alzheimer’s disease (early AD).
Optimistic about the drug’s efficacy, the company has initiated its submission for accelerated FDA approval.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.
A team of neuroscientists at UNLV has reinforced the evidence for a link between type II diabetes and Alzheimer's disease.
A team of neuroscientists from the University of Nevada, Las Vegas-UNLV confirms the link between type II diabetes and Alzheimer's disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer's disease.
A team of UNLV neuroscientists has strengthened the link between Type II diabetes and Alzheimer’s disease.
A new program at UNLV is addressing a critical healthcare shortage in the Las Vegas valley.
The occupational therapists in training at UNLV will one day work with people recovering from strokes, injury — and COVID-19.
Picture of UNLV School of Integrated Health Sciences students working on mobility training practices with infant dolls at the Occupational Therapy lab facility at the Shadow Lane campus.